The UK NSC recommendation on Familial hypercholesterolaemia screening in children
Find general information about population health screening.
Why is screening not recommended by UK NSC?
Screening is not recommended because:
More about Familial Hypercholesterolaemia (child)
Familial hypercholesterolaemia (FH) is a condition where the body has a high amount of a fatty substance called cholesterol. The build-up and hardening of these fatty substances can block blood from being supplied to the heart and other areas of the body. This causes heart disease leading to serious illness and can cause death.
FH is passed on to those affected at birth through altered genes from either mother or father and in some cases through both. People with FH have a 1 in 2 chance of passing on the condition to their children. Around 1
Without the right healthcare people with FH are more likely to develop types of heart disease at an early age. NICE clinical guidance on the identification and managementof FH (CG71) recommend that treatment with lipid-modifying therapy should usually be considered by 10 years of age, and would be lifelong.
• AntiCoagulation Europe
The stakeholder groups will be involved when the recommendation is next reviewed. If you think your organisation should be added, please contact us. More information for stakeholders can be found in appendix C of the UK NSC evidence review process.
More optionsGo to top